Terek Peterson
Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, will share its expertise in biopharmaceuticals, medical devices and combination products at conferences in February.
Terek Peterson, Theorem’s senior director of global statistics, and Prithul Bom, Theorem’s director of medical device development, will both make presentations at Outsourcing in Clinical Trials (OCT) West Coast in San Francisco. Peterson will outline important information developers need to know about the FDA’s long-awaited binding data standards guidance at 2:15 p.m. Feb. 3. An industry expert on medical device software regulations and standards, Bom will discuss mobile medical applications at 11:40 a.m. Feb. 4.
Prithul Bom
D. Lee Spurgin Jr., Ph.D., Theorem’s senior vice president and general manager for medical device and diagnostic development, will provide a guide to country selection in the Asia-Pacific for medical device trials at the Clinical Operations and Outsourcing in Medical Device Trials conference in Munich, Germany. His presentation begins at 10 a.m. Feb. 10.
“We look forward to sharing our expertise in medical devices, diagnostics and drug-device combination products,” said Spurgin. “These three presentations will answer some of the questions we often hear from sponsors and other CROs, and we’ll discuss some critical deadlines and opportunities that developers should be considering.”
Lee Spurgin
Over three decades, the Theorem team has performed scores of global biopharmaceutical and medical device trials across all approval pathways, as well as dozens of drug/device combination trials. Theorem conducts trials of every size, including those in new and emerging markets.
See Theorem at Booth 3 at OCT West Coast and at Stand 7 at the Outsourcing in Medical Device Trials conference in Germany. Learn more about Theorem, its services and therapeutic areas of expertise at theoremclinical.com.